MYO5A and pancreatic adenocarcinoma: The expression of ACTB, ACTG1, ACTN4, ACTR2, ACTR3, ANLN, AP2A1, ARPC4, CAPZA2, CAPZB, CFL1, CLTA, CLTB, CORO1B, CORO1C, DAB2, DBN1, EPS15, FLNA, FLNB, INF2, IQGAP1, LIMA1, MYH9, MYO18A, MYO5A, SPTAN1, SPTBN1, SVIL, SYNPO, TMOD3, TPM1, and WDR1 were significantly increased in PAAD tissue (P < 0.05) (Supplementary File 3).